| |
|
|
|
|
|
|
|||
|
Blood, 15 June 2006, Vol. 107, No. 12, pp. 4714-4720. Prepublished online as a Blood First Edition Paper on January 17, 2006; DOI 10.1182/blood-2005-09-3584.
Submitted September 6, 2005
Hematology-Oncology, Case Western Reserve University School of Medicine, Cleveland, OH, USA * Corresponding author; email: keith.mccrae{at}case.edu.
High molecular weight kininogen (HK) is an abundant plasma protein that plays a central role in activation of the kallikrein-kinin system. Cleavage of HK by plasma kallikrein results in release of the nonapeptide bradykinin (BK), leaving behind cleaved high molecular weight kininogen (HKa). Previous studies have demonstrated that HKa induces apoptosis of proliferating endothelial cells and inhibits angiogenesis in vivo, activities mediated primarily through its domain 5. However, the mechanisms by which these effects occur are not well understood. Here, we demonstrate that HKa induces apoptosis of endothelial cells cultured on gelatin, vitronectin, fibronectin or laminin, but not collagen types I or IV. The ability of HKa to induce endothelial cell apoptosis is dependent on the generation of intracellular reactive oxygen species, and associated with depletion of glutathione and peroxidation of endothelial cell lipids, effects that occur only in cells cultured on matrix proteins permissive for HKa-induced apoptosis. Finally, the ability of HKa to induce endothelial cell apoptosis is blocked by the addition of reduced glutathione or N-acetyl cysteine. These studies demonstrate a unique role for oxidant stress in mediating the activity of an antiangiogenic polypeptide, and highlight the importance of the extracellular matrix in regulating endothelial cell survival.
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2006 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||